ImmuCell Corp (ICCC)
5.04
+0.01
(+0.20%)
USD |
NASDAQ |
Apr 24, 16:00
5.05
+0.01
(+0.20%)
After-Hours: 20:00
ImmuCell Price to Book Value: 1.563 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.563 |
| April 23, 2024 | 1.560 |
| April 22, 2024 | 1.560 |
| April 19, 2024 | 1.557 |
| April 18, 2024 | 1.566 |
| April 17, 2024 | 1.566 |
| April 16, 2024 | 1.566 |
| April 15, 2024 | 1.572 |
| April 12, 2024 | 1.557 |
| April 11, 2024 | 1.591 |
| April 10, 2024 | 1.613 |
| April 09, 2024 | 1.619 |
| April 08, 2024 | 1.650 |
| April 05, 2024 | 1.603 |
| April 04, 2024 | 1.603 |
| April 03, 2024 | 1.611 |
| April 02, 2024 | 1.625 |
| April 01, 2024 | 1.616 |
| March 28, 2024 | 1.644 |
| March 27, 2024 | 1.640 |
| March 26, 2024 | 1.600 |
| March 25, 2024 | 1.628 |
| March 22, 2024 | 1.622 |
| March 21, 2024 | 1.578 |
| March 20, 2024 | 1.578 |
| Date | Value |
|---|---|
| March 19, 2024 | 1.538 |
| March 18, 2024 | 1.548 |
| March 15, 2024 | 1.628 |
| March 14, 2024 | 1.597 |
| March 13, 2024 | 1.585 |
| March 12, 2024 | 1.582 |
| March 11, 2024 | 1.620 |
| March 08, 2024 | 1.613 |
| March 07, 2024 | 1.613 |
| March 06, 2024 | 1.628 |
| March 05, 2024 | 1.644 |
| March 04, 2024 | 1.693 |
| March 01, 2024 | 1.637 |
| February 29, 2024 | 1.637 |
| February 28, 2024 | 1.619 |
| February 27, 2024 | 1.594 |
| February 26, 2024 | 1.606 |
| February 23, 2024 | 1.594 |
| February 22, 2024 | 1.613 |
| February 21, 2024 | 1.544 |
| February 20, 2024 | 1.585 |
| February 16, 2024 | 1.597 |
| February 15, 2024 | 1.557 |
| February 14, 2024 | 1.551 |
| February 13, 2024 | 1.563 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.943
Minimum
Mar 31 2020
3.039
Maximum
Apr 30 2021
1.712
Average
1.569
Median
Jul 08 2019
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.706 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7198 |
| Theriva Biologics Inc | 0.171 |
| Oragenics Inc | 3.100 |
Price to Book Value Related Metrics
| PS Ratio | 2.235 |
| PEG Ratio | -0.0473 |
| Price | 5.04 |
| Earnings Yield | -14.88% |
| Market Cap | 39.06M |
| PEGY Ratio | -0.0473 |